Navigation Links
Intercept Pharmaceuticals Announces Positive Phase II Results for Obeticholic Acid (INT-747) as Monotherapy in Primary Biliary Cirrhosis
Date:3/31/2011

ipal investigator in the study, commented, "There is a real need for novel therapies in PBC.  The clinically meaningful results from this study are highly supportive of OCA's potential as an effective new drug. We know now that OCA is effective given both in addition to UDCA and, from this study, when given alone.  The reductions in AP levels were very substantial and occurred within a month.  The effects on IgM and inflammatory markers suggest that OCA may have disease modifying properties."

Intercept's Chief Medical Officer, David Shapiro, MD, commented, "This study involved 20 centers in 7 countries and has given us and the PBC thought leaders involved a better understanding of the potent mechanism of action of OCA.  With the international PBC network we have established, we are well positioned to conduct a Phase III program.  We are currently discussing requirements for approval with FDA and have received guidance from the EMA supportive of our proposed program."

Mark Pruzanski, MD, Intercept's Chief Executive Officer, added, "The remarkable results achieved with OCA treatment in this study, together with the previously announced positive Phase II results with our drug added to UDCA in refractory PBC patients and in diabetic patients with nonalcoholic fatty liver disease, supports OCA's potential as a novel hepatoprotective drug that may help preserve liver function in patients with a variety of chronic liver diseases."

About Obeticholic Acid (OCA or INT-747)

OCA is a potent, first-in-class farnesoid X receptor (FXR) agonist derived from the primary human bile acid chenodeoxycholic acid, the natural endogenous FXR agonist. Intercept has announced positive Phase II results from randomized clinical trials in patients with primary biliary cirrhosis (PBC), the most common autoimmune liver disease, and in type 2 diabetics with nonalcoholic fatty liver disease.  These clinical data and OCA's mechanism
'/>"/>

SOURCE Intercept Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dainippon Sumitomo Pharma and Intercept Pharmaceuticals Announce Agreement to Develop and Commercialize Obeticholic Acid (INT-747) for Chronic Liver Disease
2. Initiation of FLINT Announced by NIDDK: Study of Intercept Pharmaceuticals Obeticholic Acid (INT-747) in NASH
3. Intercept Pharmaceuticals to Collaborate With NIDDK on Study of Obeticholic Acid (INT-747) in Nonalcoholic Steatohepatitis (NASH)
4. Intercept Pharmaceuticals Raises $25 Million Series B Financing
5. Intercept Pharmaceuticals Announces Positive Phase II Results for INT-747 as a Treatment for Primary Biliary Cirrhosis
6. Intercept Pharmaceuticals FXR Agonist INT-747 Meets Primary Endpoint in a Phase II Clinical Trial in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease
7. Reportlinker Adds Top 500 Pharmaceuticals Industry Report (Global)
8. Reportlinker Adds Top 200 Biopharmaceuticals Industry Report (Global)
9. Syndax Pharmaceuticals Announces Entinostat Data at 102nd Annual American Association for Cancer Research Meeting
10. Vanda Pharmaceuticals to Evaluate Tasimelteon in Major Depression
11. Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... PORTLAND, Oregon , November 26, 2014 ... or fascia of the organ protrudes through the wall of ... weak muscle area at birth are some of the causes ... inguinal, umbilical, hiatal, femoral, and incisional. An inguinal hernia is ... area. An umbilical hernia is found in the area of ...
(Date:11/26/2014)... YORK , Nov. 26, 2014 ... growing at a rate of 4%, with world ... to Kalorama Information. MRI and other types of ... diagnosis and treatment of numerous medical conditions in ... technologies and techniques. Kalorama,s report, Medical Imaging ...
(Date:11/26/2014)... SAN FRANCISCO , Nov. 25, 2014  goBalto, ... solutions, has been recognized as a winner of Red ... received a Global Top 100 North America award in ... the international technology landscape. Red Herring,s Top ... for identifying promising new companies and entrepreneurs. Red Herring ...
Breaking Medicine Technology:Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 3Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 4Kalorama: Steady Growth in the Medical MRI Market 2Kalorama: Steady Growth in the Medical MRI Market 3goBalto Selected as a 2014 Red Herring Top 100 Global Company 2goBalto Selected as a 2014 Red Herring Top 100 Global Company 3
... SAN DIEGO, April 25, 2011 Pharmatek Laboratories, ... supporting the pharmaceutical industry, announced that it has ... manufacturing capabilities.  The company has purchased a Buchi ... and small-scale clinical manufacture.  This technology can be ...
... Uroplasty, Inc. (NASDAQ: ... manufactures and markets innovative proprietary products to treat ... clinical studies using Uroplasty,s Urgent® PC Neuromodulation System ... to be presented at three upcoming professional meetings. ...
Cached Medicine Technology:Pharmatek Laboratories Adds Spray Drying to Drug Development Services 2Clinical Studies Results of Uroplasty Products Scheduled for Presentation at Three Professional Meetings 2Clinical Studies Results of Uroplasty Products Scheduled for Presentation at Three Professional Meetings 3
(Date:11/27/2014)... (PRWEB) November 27, 2014 Blood-borne pathogens ... many medical precautions and procedures in place to counter ... and disposal of things tainted with menstrual blood are ... design a simpler, more sanitary way to handle tampons ... an inventor from Sonora, Calif. , He then created ...
(Date:11/27/2014)... Dotinga HealthDay Reporter , WEDNESDAY, ... pre-wired to acquire a second language, new research suggests. But ... likely gain a brain boost, the small study finds. ... said study co-author Ping Li, co-director of the Center for ... even more interesting, Li said, that "the brain networks of ...
(Date:11/27/2014)... PITTSBURGH, PA (PRWEB) November 27, 2014 In ... an inventor from Sharpes, Fla., designed an easy way to ... lowering it/them. , He then created a prototype of the ... lift or lower a toilet seat and/or lid in a ... which prevents the spread of germs. Overall, it promotes good ...
(Date:11/27/2014)... November 27, 2014 Tylenol lawsuits ( ... allegedly injured by the medication are continuing to move ... is looking ahead to a status conference in December, ... Scheduling Order issued earlier this year, a conference in ... at 10:00 a.m. Items likely to be discussed at ...
(Date:11/27/2014)... DC (PRWEB) November 27, 2014 “LAB.C” was ... which features the latest and coolest technology products available to ... conducted the product review and shared with viewers ... for iOS and Android devices. , Consumers love portability and ... Their Cable Case for the iPhone5 and 5S has ...
Breaking Medicine News(10 mins):Health News:Some People May Be Pre-Wired to Be Bilingual 2Health News:Some People May Be Pre-Wired to Be Bilingual 3Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 2Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 3Health News:Top Mobile Friendly Accessories were Featured on NewsWatch Television on October 30, 2014 2
... be more effective than a "fat" tax for deterring overweight ... study has found. A survey of 364 shoppers in random ... people from reaching for junk food, shoppersincluding those with the ... high fat content and included a note that the item ...
... D.C. It is important that the United States begin to ... APS believes that as a nation we need to be smart ... a clear understanding of what it means for America,s future jeopardizes ... For more than half a century, science and technology have been ...
... (HealthDay News) -- A lack of leptin contributes to the ... of body fat, but treatment with a synthetic form of ... a new study indicates. Extremely low levels of body ... as runners and dancers, and in those with eating disorders. ...
... April 8, 2011 Increased levels of a protein ... a major cardiovascular event in high-risk patients, according to a ... Measuring the amount of the protein, known as plasma renin ... tool to assess a patient,s risk and help prevent a ...
... HealthDay Reporter , THURSDAY, April 7 (HealthDay ... stroke appears to promote arm strength and function, Canadian ... approaches -- including the use of virtual reality [gaming] ... social participation," said lead researcher Dr. Gustavo Saposnik, director ...
... 2011A growing body of research suggests that caffeine disrupts ... poor control of type 2 diabetes, a major public ... of Journal of Caffeine Research : The International ... from Mary Ann Liebert, Inc. publishers, examines the latest ...
Cached Medicine News:Health News:Warning labels better than a fat tax, University of Alberta study shows 2Health News:US House budget plans would jeopardize scientific research facilities 2Health News:Hormone Linked to Absence of Periods in Women With Low Body Fat 2Health News: Video Games Might Aid in Stroke Rehab 2Health News: Video Games Might Aid in Stroke Rehab 3Health News:Caffeine and diabetes -- helpful or harmful? 2
5.5 pointed curved blade. Octagonal handle....
0.5 mm wide x 1.5 mm long. Angled 20 degrees. Octagonal handle....
2 mm wide curved tip. Round handle....
8 mm downcutting Royce blade. Angled shaft. 60 mm from angle to tip....
Medicine Products: